1271728-79-0

Basic information

• Product Name: tert-butyl 3-(2-(2-azidoethoxy)ethoxy)propanoate
• CAS NO: 1271728-79-0
• Molecular Weight: 259.305
• Mol File: 1271728-79-0.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: tert-butyl 3-(2-(2-azidoethoxy)ethoxy)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-(2-(2-azidoethoxy)ethoxy)propanoate(1271728-79-0)
• EPA Substance Registry System: tert-butyl 3-(2-(2-azidoethoxy)ethoxy)propanoate(1271728-79-0)

Safety Data

• Hazardous Substances Data: 1271728-79-0(Hazardous Substances Data)

Usage

Description

Azido-PEG2- t-butyl ester is a azide containing PEG compound. The azide (N3) group is reactive with BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The t-butyl protected carboxyl group can be deprotected under acidic conditions.

Upstream product

• 133803-81-3 2-methyl-2-propanyl 3-[2-(2-hydroxyethoxy)ethoxy]propanoate 
• 1938057-43-2 tert-butyl 3-(2-(2-iodoethoxy)ethoxy)propanoate 
• 1312309-62-8 tert-butyl 3-(2-(2-((methylsulfonyl)oxy)ethoxy)ethoxy)propanoate 
• 1663-39-4 tert-Butyl acrylate 
• 850090-13-0 9-(p-toluenesulfonyloxy)-3,6-diocanonanoic acid tert-butyl ester 

Downstream Products

• 1312309-63-9 3-(2-(2-azidoethoxy)ethoxy)propanoic acid 
• 1610796-02-5 2,5-dioxopyrrolidin-1-yl-3 (2-(2-azidoethoxy)ethoxy)propanoate 
• 756525-95-8 2-methyl-2-propanyl 3-[2-(2-aminoethoxy)ethoxy]propanoate 

Relevant articles and documents

Synthesis of KUE-siRNA Conjugates for Prostate Cancer Cell-Targeted Gene Silencing

The delivery of siRNAs to selectively target cells poses a great challenge in RNAi-based cancer therapy. The lack of suitable cell-targeting methods seriously restricts the advance in delivering siRNAs to extrahepatic tissues. Based on prostate-specific m

NOVEL CONNECTED BODY AND USE THEREOF IN SPECIFIC CONJUGATION BETWEEN BIOMOLECULE AND DRUG

PROBLEM TO BE SOLVED: To provide: a method for producing a connected body; a method for using the connected body in the production of a uniform conjugate; and a method for applying the conjugate in the treatment of cancer, infectious diseases, and autoimmune diseases. SOLUTION: A novel connected body is provided that includes a 2,3-di-substituted succinic acid group or a 2-mono-substituted or 2,3-di-substituted fumaric acid or maleic acid (trans (E)- or cis (Z)-butenedioic acid) group for conjugating 2 or more compounds/cytotoxic agents per connected body with a cell-binding molecule by specifically bridge-linking to a pair of thiol on the cell-binding molecule. The connected body is exemplified by the following general formula. SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES

A novel cross-linked cytotoxic agents, pyrrolobenzo-diazepine dimer (PBD) derivatives, and their conjugates to a cell-binding molecule, a method for preparation of the conjugates and the therapeutic use of the conjugates.